Vivos Inc., a radiation oncology medical device company, engages in the development of yttrium-90-based precision radionuclide therapy devices for the treatment of non-resectable tumors in the United States. The company develops RadioGel, which is an injectable particle-gel for Precision...
35 insider purchases on record · latest filing 2026-08-10.
Insiders have also filed 2 sale transactions at RDGL.